Literature DB >> 21317792

Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy.

Mies A Korteweg1, Wouter B Veldhuis, Fredy Visser, Peter R Luijten, Willem P Th M Mali, Paul J van Diest, Maurice A A J van den Bosch, Dennis J Klomp.   

Abstract

OBJECTIVES: To evaluate the feasibility of 7T breast magnetic resonance imaging (MRI) by determining the intrinsic sensitivity gain compared with 3T in healthy volunteers and to explore clinical application of 7T MRI in breast cancer patients receiving neoadjuvant chemotherapy (NAC).
MATERIALS AND METHODS: In 5 volunteers, the signal-to-noise ratio (SNR) was determined on proton density MRI at 3T using a conventional 4-channel bilateral breast coil and at 7T using a dedicated 2-channel unilateral breast coil, both obtained at identical scan parameters. Subsequently, consecutive breast cancer patients on NAC were included. The 7T breast MRI protocol consisted of diffusion-weighted imaging, 3D high-resolution (450 μm isotropic) T1-weighted fat-suppressed gradient-echo sequences and quantified single voxel (1)H-magnetic resonance spectroscopy. Morphology was scored according to the MRI Breast Imaging-Reporting and Data System (BI-RADS)-lexicon, and the images were compared with 3T and histopathologic findings. Image quality was evaluated using a 5-point scale.
RESULTS: A 5.7-fold higher SNR was measured at 7T than at 3T, which reflects the advantages of a higher field strength and the use of optimized radiofrequency coils. Three breast cancer patients were included and received a total of 13 7T MRI examinations. The image quality of the high-resolution examinations was at least satisfactory, and good to excellent in 9 of the 13 examinations performed. More anatomic detail was depicted at 7T than at 3T. In 1 case, a fat plane between the muscle and tumor was visible at 7T, but not at the clinically performed 3T examination, suggesting that there was no muscle invasion, which was confirmed by pathology. Changes in tumor apparent diffusion coefficient values could be monitored in 2 patients and were found to increase during NAC, consistent with published results from studies at lower field strengths. Apparent diffusion coefficient values increased respectively from 0.33 × 10(-3) mm(2)/s to 1.78 × 10(-3) mm(2)/s after NAC and from 1.20 × 10(-3) mm(2)/s to 1.44 × 10(-3) mm(2)/s during NAC. Choline concentrations as low as 0.77 mMol/kg(water) could be detected. In 1 patient, choline levels showed an overall decrease from 4.2 mMol/kw(water) to 2.6 mMol/kg(water) after NAC and the tumor size decreased correspondingly from 3.9 × 4.1 × 5.6 cm(3) to 2.0 × 2.7 × 2.4 cm(3). All 7T MRI findings were consistent with pathology analysis.
CONCLUSION: Dedicated 7T breast MRI is technically feasible, can provide more SNR than at 3T, and has diagnostic potential.

Entities:  

Mesh:

Year:  2011        PMID: 21317792     DOI: 10.1097/RLI.0b013e31820df706

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  26 in total

1.  Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison.

Authors:  S Gruber; L Minarikova; K Pinker; O Zaric; M Chmelik; B Strasser; P Baltzer; T Helbich; S Trattnig; W Bogner
Journal:  Eur Radiol       Date:  2015-08-27       Impact factor: 5.315

2.  Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 Tesla.

Authors:  Bertine L Stehouwer; Dennis W J Klomp; Maurice A A J van den Bosch; Mies A Korteweg; Kenneth G A Gilhuijs; Arjen J Witkamp; Paul J van Diest; Karel A F Houwert; Wybe J M van der Kemp; Peter R Luijten; W P Th M Mali; Wouter B Veldhuis
Journal:  Eur Radiol       Date:  2013-08-28       Impact factor: 5.315

3.  Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.

Authors:  K Pinker; W Bogner; P Baltzer; S Trattnig; S Gruber; O Abeyakoon; M Bernathova; O Zaric; P Dubsky; Z Bago-Horvath; M Weber; D Leithner; T H Helbich
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

4.  Toward 7T breast MRI clinical study: safety assessment using simulation of heterogeneous breast models in RF exposure.

Authors:  Xin Li; Joseph V Rispoli
Journal:  Magn Reson Med       Date:  2018-09-14       Impact factor: 4.668

5.  Breast MRI at 7 Tesla with a bilateral coil and robust fat suppression.

Authors:  Ryan Brown; Pippa Storey; Christian Geppert; KellyAnne McGorty; Ana Paula Klautau Leite; James Babb; Daniel K Sodickson; Graham C Wiggins; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2013-10-07       Impact factor: 4.813

6.  Detection of microcalcifications by characteristic magnetic susceptibility effects using MR phase image cross-correlation analysis.

Authors:  Richard A Baheza; E Brian Welch; Daniel F Gochberg; Melinda Sanders; Sara Harvey; John C Gore; Thomas E Yankeelov
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

7.  Experimental and numerical analysis of B1(+) field and SAR with a new transmit array design for 7T breast MRI.

Authors:  Junghwan Kim; Narayan Krishnamurthy; Tales Santini; Yujuan Zhao; Tiejun Zhao; Kyongtae Ty Bae; Tamer S Ibrahim
Journal:  J Magn Reson       Date:  2016-04-23       Impact factor: 2.229

8.  [Molecular breast imaging. An update].

Authors:  K Pinker; T H Helbich; H Magometschnigg; B Fueger; P Baltzer
Journal:  Radiologe       Date:  2014-03       Impact factor: 0.635

9.  Measuring renal tissue relaxation times at 7 T.

Authors:  Xiufeng Li; Patrick J Bolan; Kamil Ugurbil; Gregory J Metzger
Journal:  NMR Biomed       Date:  2014-10-23       Impact factor: 4.044

10.  Breast MRI at 7 Tesla with a bilateral coil and T1-weighted acquisition with robust fat suppression: image evaluation and comparison with 3 Tesla.

Authors:  Ryan Brown; Pippa Storey; Christian Geppert; KellyAnne McGorty; Ana Paula Klautau Leite; James Babb; Daniel K Sodickson; Graham C Wiggins; Linda Moy
Journal:  Eur Radiol       Date:  2013-07-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.